News
Veracio stellt die nächste Generation von Erzkörpertechnologien für grundlegende Veränderung der Mineralexploration und des Bergbaus vor
SALT LAKE CITY, March 02, 2024 (GLOBE NEWSWIRE) -- Veracio, ein Technologieunternehmen für Wissen im Bereich der Erzkörper, das früher als Abteilung für geologische Datendienste von Boart Longyear
International Directional Services und Veracio kündigen strategische Partnerschaft zur Förderung von Bohr- und Bohrlochtechnologien in Nordamerika an
WATSONVILLE, Kalifornien, und SALT LAKE CITY, Dec. 08, 2023 (GLOBE NEWSWIRE) -- International Directional Services (IDS), ein Unternehmen von Granite (NYSE:GVA), und Veracio, ein führendes
Ensuring Security in the World of Binary Options Trading: A Look at the Underlying Technology
Clinigen Launches Malaysia Office to Strengthen Presence in Southeast Asia
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has launched its Malaysian business with an office in Kuala Lumpur. The new office is part of Clinigen’s
Clinigen Expands Partnership With Accord Healthcare in Clinical Services Into France
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that its Clinical Services (CS) business has expanded its exclusive ’on-demand’ supply service
Clinigen: IL-2 Plays Role in Emerging TIL Therapies
Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company acknowledges the presentation of results from the Phase I trial “Durable complete responses
Clinigen and Orphazyme launch an Early Access Program for arimoclomol in patients with Niemann-Pick disease type C
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Orphazyme A/S (ORPHA.CO, ‘Orphazyme’), a global biopharmaceutical company dedicated to
Why Entellus Medical Inc. Skyrocketed Higher Today
Hardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
Edison Inv Research Limited: Edison issues flash on Ergomed (ERGO)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
DGAP-News: Ergomed plc: Lewis Cameron, ehemals Leiter der globalen klinischen Entwicklung bei Covance, zum Chief Operating Officer ernannt
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Form 8.3 - The Vanguard Group, Inc.: Consort Medical plc
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through